Nurse Practitioner in Hardin, MT Accepting Medicare

9 Nurse Practitioner nurses found. Showing 1 - 9

Shannon M Wagenman, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17 N Miles Ave, Hardin, MT 59034 Phone: 406-665-2310

Mrs. Nicole D Turnsplenty, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10 4th St W, Suite B, Hardin, MT 59034 Phone: 406-665-4103    Fax: 406-867-4103

Linda E Troyer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 17 N Miles, Hardin, MT 59034 Phone: 406-665-2310    Fax: 406-665-9252

Tiffani Schubert, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17 N Miles Ave, Hardin, MT 59034 Phone: 406-665-2310    Fax: 406-665-9238

Dylan Jon Wiebe, FNP Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 16 N Miles Ave Ste 101, Hardin, MT 59034 Phone: 406-665-2800

Bonnie Oxford, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10 4th St W Ste B, Hardin, MT 59034 Phone: 406-665-4103

Ms. Elizabeth Michael Dvorak, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17 N Miles Ave, Hardin, MT 59034 Phone: 406-665-2310    Fax: 406-665-9238

Anna Hein, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 16 N Miles Ave Ste 101, Hardin, MT 59034 Phone: 406-665-2800

Marina Rath, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17 N Miles Ave, Hardin, MT 59034 Phone: 406-665-2310    Fax: 406-665-9238

News Archive

High BP may predict dementia in older adults with cognitive impairment

High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

Soft drink consumers exposed to unnecessary cancer risk

Public health researchers have analyzed soda consumption data in order to characterize people's exposure to a potentially carcinogenic byproduct of some types of caramel color. Caramel color is a common ingredient in colas and other dark soft drinks. The results show that between 44 and 58 percent of people over the age of six typically have at least one can of soda per day, possibly more, potentially exposing them to 4-methylimidazole (4-MEI), a possible human carcinogen formed during the manufacture of some kinds of caramel color.

Research roundup: Hospital emergency room HIV screenings; Medical device reviews; Health law impact on docs and hospitals

Physician Satisfaction With Chronic Care Processes: A Cluster-Randomized Trial Of Guided Care - The authors randomly assigned teams of physicians and their chronically ill older patients into groups that either provided Guided Care - an educated registered nurse works with a primary care practice team to enhance quality of care - or usual care. One year later, they measured "physicians' satisfaction with chronic care processes, time spent on chronic care, knowledge of their chronically ill older patients, and care coordination provided by physicians and office staff."

Leading Blue Dog suggests extending Medicare to uninsured

Leading Blue Dogs wrestle over options to increase coverage for the uninsured and extend Medicare. The Hill reports that Rep. Mike Ross, D-Ark., "who had emerged as a leader among centrist Blue Dog Democrats opposing the public health insurance option, has suggested something his colleagues consider even more drastic - opening Medicare to those under 65 without insurance. He made the suggestion in meetings with House Democratic leaders and brought the idea to the closed-door House Democratic Caucus meeting Thursday."

CREON Delayed-Release Capsules now available in US for patients with EPI

AbbVie announced that a new, higher-dose capsule of CREON (pancrelipase) Delayed-Release Capsules is commercially available in the United States. The U.S. Food and Drug Administration recently approved CREON in a 36,000 lipase-unit dose to treat patients with exocrine pancreatic insufficiency due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions.

Read more Medical News

› Verified 1 days ago